The global Liposomes Nanoparticle Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Liposomes Drugs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Liposomes Nanoparticle Drugs include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma and Pacira, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
This report aims to provide a comprehensive presentation of the global market for Liposomes Nanoparticle Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes Nanoparticle Drugs. This report contains market size and forecasts of Liposomes Nanoparticle Drugs in global, including the following market information:
Global Liposomes Nanoparticle Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomes Nanoparticle Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes Nanoparticle Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Liposomes Nanoparticle Drugs Market Segment Percentages, by Type, 2023 (%)
Liposomes Drugs
Lipid Nanoparticle Drugs
Global Liposomes Nanoparticle Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Liposomes Nanoparticle Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Retail Pharmacy
Other
Global Liposomes Nanoparticle Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Liposomes Nanoparticle Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomes Nanoparticle Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Liposomes Nanoparticle Drugs revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Liposomes Nanoparticle Drugs, market overview.
Chapter 2: Global Liposomes Nanoparticle Drugs market size in revenue.
Chapter 3: Detailed analysis of Liposomes Nanoparticle Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Liposomes Nanoparticle Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Liposomes Nanoparticle Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomes Nanoparticle Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomes Nanoparticle Drugs Overall Market Size
2.1 Global Liposomes Nanoparticle Drugs Market Size: 2023 VS 2030
2.2 Global Liposomes Nanoparticle Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liposomes Nanoparticle Drugs Players in Global Market
3.2 Top Global Liposomes Nanoparticle Drugs Companies Ranked by Revenue
3.3 Global Liposomes Nanoparticle Drugs Revenue by Companies
3.4 Top 3 and Top 5 Liposomes Nanoparticle Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Liposomes Nanoparticle Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposomes Nanoparticle Drugs Players in Global Market
3.6.1 List of Global Tier 1 Liposomes Nanoparticle Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Liposomes Nanoparticle Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposomes Nanoparticle Drugs Market Size Markets, 2023 & 2030
4.1.2 Liposomes Drugs
4.1.3 Lipid Nanoparticle Drugs
4.2 By Type - Global Liposomes Nanoparticle Drugs Revenue & Forecasts
4.2.1 By Type - Global Liposomes Nanoparticle Drugs Revenue, 2019-2024
4.2.2 By Type - Global Liposomes Nanoparticle Drugs Revenue, 2025-2030
4.2.3 By Type - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomes Nanoparticle Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Liposomes Nanoparticle Drugs Revenue & Forecasts
5.2.1 By Application - Global Liposomes Nanoparticle Drugs Revenue, 2019-2024
5.2.2 By Application - Global Liposomes Nanoparticle Drugs Revenue, 2025-2030
5.2.3 By Application - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Liposomes Nanoparticle Drugs Market Size, 2023 & 2030
6.2 By Region - Global Liposomes Nanoparticle Drugs Revenue & Forecasts
6.2.1 By Region - Global Liposomes Nanoparticle Drugs Revenue, 2019-2024
6.2.2 By Region - Global Liposomes Nanoparticle Drugs Revenue, 2025-2030
6.2.3 By Region - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Liposomes Nanoparticle Drugs Revenue, 2019-2030
6.3.2 US Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.3.3 Canada Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.3.4 Mexico Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Liposomes Nanoparticle Drugs Revenue, 2019-2030
6.4.2 Germany Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.4.3 France Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.4.4 U.K. Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.4.5 Italy Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.4.6 Russia Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.4.8 Benelux Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Liposomes Nanoparticle Drugs Revenue, 2019-2030
6.5.2 China Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.5.3 Japan Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.5.4 South Korea Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.5.6 India Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Liposomes Nanoparticle Drugs Revenue, 2019-2030
6.6.2 Brazil Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.6.3 Argentina Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liposomes Nanoparticle Drugs Revenue, 2019-2030
6.7.2 Turkey Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.7.3 Israel Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Liposomes Nanoparticle Drugs Market Size, 2019-2030
6.7.5 UAE Liposomes Nanoparticle Drugs Market Size, 2019-2030
7 Liposomes Nanoparticle Drugs Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Liposomes Nanoparticle Drugs Major Product Offerings
7.1.4 Johnson & Johnson Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Company Summary
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Liposomes Nanoparticle Drugs Major Product Offerings
7.2.4 Sun Pharmaceutical Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.2.5 Sun Pharmaceutical Key News & Latest Developments
7.3 CSPC
7.3.1 CSPC Company Summary
7.3.2 CSPC Business Overview
7.3.3 CSPC Liposomes Nanoparticle Drugs Major Product Offerings
7.3.4 CSPC Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.3.5 CSPC Key News & Latest Developments
7.4 Kinyond
7.4.1 Kinyond Company Summary
7.4.2 Kinyond Business Overview
7.4.3 Kinyond Liposomes Nanoparticle Drugs Major Product Offerings
7.4.4 Kinyond Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.4.5 Kinyond Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Liposomes Nanoparticle Drugs Major Product Offerings
7.5.4 Teva Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.5.5 Teva Key News & Latest Developments
7.6 Fudan-Zhangjiang
7.6.1 Fudan-Zhangjiang Company Summary
7.6.2 Fudan-Zhangjiang Business Overview
7.6.3 Fudan-Zhangjiang Liposomes Nanoparticle Drugs Major Product Offerings
7.6.4 Fudan-Zhangjiang Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.6.5 Fudan-Zhangjiang Key News & Latest Developments
7.7 Zydus Cadila
7.7.1 Zydus Cadila Company Summary
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila Liposomes Nanoparticle Drugs Major Product Offerings
7.7.4 Zydus Cadila Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.7.5 Zydus Cadila Key News & Latest Developments
7.8 TTY Biopharma
7.8.1 TTY Biopharma Company Summary
7.8.2 TTY Biopharma Business Overview
7.8.3 TTY Biopharma Liposomes Nanoparticle Drugs Major Product Offerings
7.8.4 TTY Biopharma Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.8.5 TTY Biopharma Key News & Latest Developments
7.9 Pacira
7.9.1 Pacira Company Summary
7.9.2 Pacira Business Overview
7.9.3 Pacira Liposomes Nanoparticle Drugs Major Product Offerings
7.9.4 Pacira Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.9.5 Pacira Key News & Latest Developments
7.10 Luye Pharma
7.10.1 Luye Pharma Company Summary
7.10.2 Luye Pharma Business Overview
7.10.3 Luye Pharma Liposomes Nanoparticle Drugs Major Product Offerings
7.10.4 Luye Pharma Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.10.5 Luye Pharma Key News & Latest Developments
7.11 Leadiant Biosciences
7.11.1 Leadiant Biosciences Company Summary
7.11.2 Leadiant Biosciences Business Overview
7.11.3 Leadiant Biosciences Liposomes Nanoparticle Drugs Major Product Offerings
7.11.4 Leadiant Biosciences Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.11.5 Leadiant Biosciences Key News & Latest Developments
7.12 Ipsen
7.12.1 Ipsen Company Summary
7.12.2 Ipsen Business Overview
7.12.3 Ipsen Liposomes Nanoparticle Drugs Major Product Offerings
7.12.4 Ipsen Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.12.5 Ipsen Key News & Latest Developments
7.13 Sayre Therapeutics
7.13.1 Sayre Therapeutics Company Summary
7.13.2 Sayre Therapeutics Business Overview
7.13.3 Sayre Therapeutics Liposomes Nanoparticle Drugs Major Product Offerings
7.13.4 Sayre Therapeutics Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.13.5 Sayre Therapeutics Key News & Latest Developments
7.14 Jazz
7.14.1 Jazz Company Summary
7.14.2 Jazz Business Overview
7.14.3 Jazz Liposomes Nanoparticle Drugs Major Product Offerings
7.14.4 Jazz Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.14.5 Jazz Key News & Latest Developments
7.15 Alnylam
7.15.1 Alnylam Company Summary
7.15.2 Alnylam Business Overview
7.15.3 Alnylam Liposomes Nanoparticle Drugs Major Product Offerings
7.15.4 Alnylam Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.15.5 Alnylam Key News & Latest Developments
7.16 Bausch Health
7.16.1 Bausch Health Company Summary
7.16.2 Bausch Health Business Overview
7.16.3 Bausch Health Liposomes Nanoparticle Drugs Major Product Offerings
7.16.4 Bausch Health Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.16.5 Bausch Health Key News & Latest Developments
7.17 Acrotech Biopharma
7.17.1 Acrotech Biopharma Company Summary
7.17.2 Acrotech Biopharma Business Overview
7.17.3 Acrotech Biopharma Liposomes Nanoparticle Drugs Major Product Offerings
7.17.4 Acrotech Biopharma Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.17.5 Acrotech Biopharma Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Liposomes Nanoparticle Drugs Major Product Offerings
7.18.4 Takeda Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.18.5 Takeda Key News & Latest Developments
7.19 Chiesi Farmaceutici
7.19.1 Chiesi Farmaceutici Company Summary
7.19.2 Chiesi Farmaceutici Business Overview
7.19.3 Chiesi Farmaceutici Liposomes Nanoparticle Drugs Major Product Offerings
7.19.4 Chiesi Farmaceutici Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.19.5 Chiesi Farmaceutici Key News & Latest Developments
7.20 Gilead Sciences
7.20.1 Gilead Sciences Company Summary
7.20.2 Gilead Sciences Business Overview
7.20.3 Gilead Sciences Liposomes Nanoparticle Drugs Major Product Offerings
7.20.4 Gilead Sciences Liposomes Nanoparticle Drugs Revenue in Global Market (2019-2024)
7.20.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Liposomes Nanoparticle Drugs Market Opportunities & Trends in Global Market
Table 2. Liposomes Nanoparticle Drugs Market Drivers in Global Market
Table 3. Liposomes Nanoparticle Drugs Market Restraints in Global Market
Table 4. Key Players of Liposomes Nanoparticle Drugs in Global Market
Table 5. Top Liposomes Nanoparticle Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Liposomes Nanoparticle Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Liposomes Nanoparticle Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Liposomes Nanoparticle Drugs Product Type
Table 9. List of Global Tier 1 Liposomes Nanoparticle Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomes Nanoparticle Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Liposomes Nanoparticle Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Liposomes Nanoparticle Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Liposomes Nanoparticle Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Liposomes Nanoparticle Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Liposomes Nanoparticle Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Liposomes Nanoparticle Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Liposomes Nanoparticle Drugs Product Offerings
Table 32. Johnson & Johnson Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Sun Pharmaceutical Company Summary
Table 35. Sun Pharmaceutical Liposomes Nanoparticle Drugs Product Offerings
Table 36. Sun Pharmaceutical Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Sun Pharmaceutical Key News & Latest Developments
Table 38. CSPC Company Summary
Table 39. CSPC Liposomes Nanoparticle Drugs Product Offerings
Table 40. CSPC Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. CSPC Key News & Latest Developments
Table 42. Kinyond Company Summary
Table 43. Kinyond Liposomes Nanoparticle Drugs Product Offerings
Table 44. Kinyond Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Kinyond Key News & Latest Developments
Table 46. Teva Company Summary
Table 47. Teva Liposomes Nanoparticle Drugs Product Offerings
Table 48. Teva Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Teva Key News & Latest Developments
Table 50. Fudan-Zhangjiang Company Summary
Table 51. Fudan-Zhangjiang Liposomes Nanoparticle Drugs Product Offerings
Table 52. Fudan-Zhangjiang Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Fudan-Zhangjiang Key News & Latest Developments
Table 54. Zydus Cadila Company Summary
Table 55. Zydus Cadila Liposomes Nanoparticle Drugs Product Offerings
Table 56. Zydus Cadila Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Zydus Cadila Key News & Latest Developments
Table 58. TTY Biopharma Company Summary
Table 59. TTY Biopharma Liposomes Nanoparticle Drugs Product Offerings
Table 60. TTY Biopharma Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. TTY Biopharma Key News & Latest Developments
Table 62. Pacira Company Summary
Table 63. Pacira Liposomes Nanoparticle Drugs Product Offerings
Table 64. Pacira Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Pacira Key News & Latest Developments
Table 66. Luye Pharma Company Summary
Table 67. Luye Pharma Liposomes Nanoparticle Drugs Product Offerings
Table 68. Luye Pharma Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Luye Pharma Key News & Latest Developments
Table 70. Leadiant Biosciences Company Summary
Table 71. Leadiant Biosciences Liposomes Nanoparticle Drugs Product Offerings
Table 72. Leadiant Biosciences Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 73. Leadiant Biosciences Key News & Latest Developments
Table 74. Ipsen Company Summary
Table 75. Ipsen Liposomes Nanoparticle Drugs Product Offerings
Table 76. Ipsen Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 77. Ipsen Key News & Latest Developments
Table 78. Sayre Therapeutics Company Summary
Table 79. Sayre Therapeutics Liposomes Nanoparticle Drugs Product Offerings
Table 80. Sayre Therapeutics Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 81. Sayre Therapeutics Key News & Latest Developments
Table 82. Jazz Company Summary
Table 83. Jazz Liposomes Nanoparticle Drugs Product Offerings
Table 84. Jazz Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 85. Jazz Key News & Latest Developments
Table 86. Alnylam Company Summary
Table 87. Alnylam Liposomes Nanoparticle Drugs Product Offerings
Table 88. Alnylam Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 89. Alnylam Key News & Latest Developments
Table 90. Bausch Health Company Summary
Table 91. Bausch Health Liposomes Nanoparticle Drugs Product Offerings
Table 92. Bausch Health Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 93. Bausch Health Key News & Latest Developments
Table 94. Acrotech Biopharma Company Summary
Table 95. Acrotech Biopharma Liposomes Nanoparticle Drugs Product Offerings
Table 96. Acrotech Biopharma Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 97. Acrotech Biopharma Key News & Latest Developments
Table 98. Takeda Company Summary
Table 99. Takeda Liposomes Nanoparticle Drugs Product Offerings
Table 100. Takeda Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 101. Takeda Key News & Latest Developments
Table 102. Chiesi Farmaceutici Company Summary
Table 103. Chiesi Farmaceutici Liposomes Nanoparticle Drugs Product Offerings
Table 104. Chiesi Farmaceutici Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 105. Chiesi Farmaceutici Key News & Latest Developments
Table 106. Gilead Sciences Company Summary
Table 107. Gilead Sciences Liposomes Nanoparticle Drugs Product Offerings
Table 108. Gilead Sciences Liposomes Nanoparticle Drugs Revenue (US$, Mn) & (2019-2024)
Table 109. Gilead Sciences Key News & Latest Developments
List of Figures
Figure 1. Liposomes Nanoparticle Drugs Segment by Type in 2023
Figure 2. Liposomes Nanoparticle Drugs Segment by Application in 2023
Figure 3. Global Liposomes Nanoparticle Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Liposomes Nanoparticle Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Liposomes Nanoparticle Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liposomes Nanoparticle Drugs Revenue in 2023
Figure 8. By Type - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 16. US Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 28. China Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Liposomes Nanoparticle Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Liposomes Nanoparticle Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Johnson & Johnson Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Sun Pharmaceutical Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. CSPC Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Kinyond Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Teva Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Fudan-Zhangjiang Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Zydus Cadila Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. TTY Biopharma Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Pacira Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Luye Pharma Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Leadiant Biosciences Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Ipsen Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Sayre Therapeutics Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Jazz Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Alnylam Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Bausch Health Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Acrotech Biopharma Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Takeda Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Chiesi Farmaceutici Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. Gilead Sciences Liposomes Nanoparticle Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
